SRI-22819

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameSRI-22819
Drug Alias NameSRI-22819
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSouthern Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSouthern Research Institute
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A